GENinCode Plc (LON:GENI – Get Free Report)’s share price reached a new 52-week low on Monday . The stock traded as low as GBX 0.90 and last traded at GBX 0.95, with a volume of 19445963 shares. The stock had previously closed at GBX 1.17.
GENinCode Stock Down 14.5%
The company has a market capitalization of £7.25 million, a price-to-earnings ratio of -0.43 and a beta of 0.61. The firm’s 50 day moving average price is GBX 1.13 and its two-hundred day moving average price is GBX 1.55. The company has a current ratio of 2.80, a quick ratio of 15.89 and a debt-to-equity ratio of 7.17.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Featured Stories
- Five stocks we like better than GENinCode
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
